Potential savings
%Annual savings
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
In less than 5 minutes this calculator will help you estimate potential savings on an annual basis with your revenue management challenges.
All inputs have a default value. Edit the values to see a detailed breakdown.
Potential savings
%Annual savings
Click the button to copy the link to your results. If you'd like to come back to this page later, bookmark this link. You'll come back to the calculator with your information saved.
Increase channel revenue forecasting and reporting
of executives recently surveyed report issues with their partner payments
Of executives shared that incentives and rebates are a challenge for their organizations
Thank you for your interest in Model N. Please submit the form and our sales team will contact you within 24 hours.
We look forward to responding within one business day.